Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-054537
Filing Date
2012-10-11
Accepted
2012-10-11 19:56:16
Documents
1
Period of Report
2012-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd358150.html 4  
1 FORM 4 rrd358150.xml 4 6747
  Complete submission text file 0001181431-12-054537.txt   8369
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Reporting) CIK: 0000874015 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 121140880
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations